naratriptan
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
87063-288 -
Package NDC
87063-288-09 -
Package NDC
87063-288-12 -
Package NDC
87063-288-30 -
Package NDC
87063-288-60 -
Package NDC
87063-288-90 -
Application number
ANDA200502 -
SPL ID
586e484f-099e-4e71-e063-6294a90af7d1 -
SPL set ID
63ea356f-0895-4540-b242-8e611eacd938 -
UNII
10X8X4P12Z -
RxCUI
311918 -
RxCUI
314135
What the source publishes
- Labeler
- ASCLEMED USA INC.
- Active ingredients
- naratriptan
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "naratriptan",
"splId": "586e484f-099e-4e71-e063-6294a90af7d1",
"labels": [
{
"setId": "63ea356f-0895-4540-b242-8e611eacd938",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=63ea356f-0895-4540-b242-8e611eacd938",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=63ea356f-0895-4540-b242-8e611eacd938"
}
],
"routes": [
"ORAL"
],
"labeler": "ASCLEMED USA INC.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "9 TABLET in 1 BLISTER PACK (87063-288-09)",
"package_ndc": "87063-288-09",
"identifierStatus": "well-formed",
"marketing_start_date": "20260807"
},
{
"sample": false,
"description": "12 TABLET in 1 BOTTLE (87063-288-12)",
"package_ndc": "87063-288-12",
"identifierStatus": "well-formed",
"marketing_start_date": "20260807"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (87063-288-30)",
"package_ndc": "87063-288-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20260807"
},
{
"sample": false,
"description": "60 TABLET in 1 BOTTLE (87063-288-60)",
"package_ndc": "87063-288-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20260807"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (87063-288-90)",
"package_ndc": "87063-288-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20260807"
}
],
"productId": "87063-288_586e484f-099e-4e71-e063-6294a90af7d1",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "87063-288",
"deaSchedule": null,
"genericName": "naratriptan",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NARATRIPTAN HYDROCHLORIDE",
"strength": "2.5 mg/1"
}
],
"applicationNumber": "ANDA200502",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20110315",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"10X8X4P12Z"
],
"rxcui": [
"311918",
"314135"
],
"spl_set_id": [
"63ea356f-0895-4540-b242-8e611eacd938"
],
"manufacturer_name": [
"ASCLEMED USA INC."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:87063-288_586e484f-099e-4e71-e063-6294a90af7d1"